SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M.M.HoffmannKleine-Weber, H.H.Kleine-WeberSchroeder, S.S.SchroederKr?ger, N.N.Kr?gerHerrler, T.T.HerrlerErichsen, S.S.ErichsenSchiergens, T.S.T.S.SchiergensHerrler, G.G.HerrlerNAI-HUEI WUNitsche, A.A.NitscheM?ller, M.A.M.A.M?llerDrosten, C.C.DrostenP?hlmann, S.S.P?hlmann2020-10-062020-10-062020https://scholars.lib.ntu.edu.tw/handle/123456789/516496SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitorjournal article10.1016/j.cell.2020.02.0522-s2.0-85082190084